Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Bank Ganesha Tbk (BGTG) vs Dharma Polimetal Tbk. (DRMA)

Bank Ganesha TbkTrading
Dharma Polimetal Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Bank Ganesha Tbk dan Dharma Polimetal Tbk.: Bank Ganesha Tbk diperdagangkan di Rp110 (kapitalisasi pasar 2,59 T, volume 24 jam 543,6 rb), sedangkan Dharma Polimetal Tbk. diperdagangkan di Rp900 (kapitalisasi pasar 4,24 T, volume 24 jam 134,1 rb). Perbedaan utamanya: Dharma Polimetal Tbk. lebih besar dari sisi kapitalisasi pasar, dan Bank Ganesha Tbk lebih aktif diperdagangkan (543,6 rb vs 134,1 rb). Mana yang lebih baik tergantung tujuan investasimu.

BGTGDRMA
Kapitalisasi Pasar
2,59 T4,24 T
Volume
543,6 rb134,1 rb
Lot
5,44 rb1,34 rb
Perputaran
59,52 jt120,97 jt
Harga Rata-rata
109,49902,07
Nilai Transaksi
59,52 jt120,97 jt
Harga Ekuilibrium Indikatif
110900
Volume Ekuilibrium Indikatif
874

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

BGTG
Lihat detail
DRMA
Lihat detail

Tentang Bank Ganesha Tbk

P.T. Bank Ganesha Tbk (”the Bank”) was established based on Deed No. 47 dated May 15, 1990 of notary Esther Daniar Iskandar S.H. The Bank started commercial operations on April 30, 1992 when it obtained its business license based on the Decision Letter No. 393/KMK-013/1992 dated April 14, 1992 from the Minister of Finance of the Republic of Indonesia. In accordance with Bank Indonesia’sDecision Letter No. 26/66/KEP/DIR dated September 12, 1995, the Bank is authorized to be a foreign exchange bank.

Selengkapnya di halaman BGTG

Tentang Dharma Polimetal Tbk.

PT Dharma Polimetal Tbk (“the Company”) was established in the Republic of Indonesia on 27 March based on Notarial deed No. 74 of Rukmasanti Hardjasatya, S.H. The Company begin opertions on year 1989 and commenced its commercial activities since 1990. The Company’s Majority shareholder is PT Dharma Inti Anugerah, established in Republic Indonesia on 20 November 2003.

Selengkapnya di halaman DRMA